Skip to main content
OpenTrials
Completed

NCT Number: NCT05097118

Surgical Site Infiltration Using Ketamine Versus Bupivacaine for Analgesia in Post-operative Appendectomy Operation

surgical site infiltration using ketamine versus Bupivacaine for analgesia in post-operative Appendectomy operation by Ketamine versus Bupivacaine

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Appendicitis Acute Appendicitis Cecal Diseases Digestive System Diseases Gastroenteritis Gastrointestinal Diseases Infections Intestinal Diseases Intraabdominal Infections

Age range

14 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Sohag University Hospital

Sohag, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 60 adult patients with ASA physical physical status class 1 and class 2 undergoing uncomplicated appendectomy under general anesthesia

Exclusion criteria

  • Patient refusal
  • drug abuse
  • Patient with neurological, psychiatirc or neuromuscular disease
  • chronic pain on medicine
  • known allergy to the study medicine
  • Infection at the site of infiltration

Treatment and study plan

Ketamine Versus Bupivacaine

Drug

Drugs Ketamine versus Bupivacaine

Primary outcomes

  1. Comparison study between Ketamine and Bupivacaine for post operative analgesia

    Time frame: one year

    Analgesia for post -operative Appendectomy operation

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Oct 27, 2021
Registry last updated
Oct 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.